COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests.
作者信息
Chen Lijuan, Lou Jianghua, Bai Yan, Wang Meiyun
机构信息
Department of Medical Imaging, Henan Provincial People's Hospital & the People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
出版信息
Am J Gastroenterol. 2020 May;115(5):790. doi: 10.14309/ajg.0000000000000610.
Abstract
摘要
相似文献
1
COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests.粪便病毒检测呈阳性而咽拭子和痰液病毒检测呈阴性的COVID-19疾病
Am J Gastroenterol. 2020 May;115(5):790. doi: 10.14309/ajg.0000000000000610.
2
SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19.新型冠状病毒肺炎患者咽拭子转阴后痰液和粪便中仍存在严重急性呼吸综合征冠状病毒2阳性
Ann Intern Med. 2020 Jun 16;172(12):832-834. doi: 10.7326/M20-0991. Epub 2020 Mar 30.
3
Viral load of SARS-CoV-2 in clinical samples.临床样本中新型冠状病毒2的病毒载量
Lancet Infect Dis. 2020 Apr;20(4):411-412. doi: 10.1016/S1473-3099(20)30113-4. Epub 2020 Feb 24.
4
SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients.在康复期新冠患者的诱导痰中比在咽拭子中更容易检测到严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA。
Lancet Infect Dis. 2020 Jun;20(6):655-656. doi: 10.1016/S1473-3099(20)30174-2. Epub 2020 Mar 12.
5
The Sampling Locations are Closely Related to the Positive Rate of Novel Coronavirus Nucleic Acid Detection.采样地点与新型冠状病毒核酸检测阳性率密切相关。
Clin Lab. 2020 Jun 1;66(6). doi: 10.7754/Clin.Lab.2020.200431.
6
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
7
Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.一名新冠肺炎康复患者痰液中新冠病毒2型检测呈阳性结果。
Travel Med Infect Dis. 2020 Mar-Apr;34:101619. doi: 10.1016/j.tmaid.2020.101619. Epub 2020 Mar 8.
8
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.
9
Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.痰和粪便中的病毒核酸与血清特异性 IgM/IgG 对 2019 年冠状病毒病的诊断价值。
Front Cell Infect Microbiol. 2020 Aug 6;10:445. doi: 10.3389/fcimb.2020.00445. eCollection 2020.
10
Positive results for patients with COVID-19 discharged form hospital in Chongqing, China.中国重庆出院的 COVID-19 患者呈阳性结果。
BMC Infect Dis. 2020 Jun 19;20(1):429. doi: 10.1186/s12879-020-05151-y.
引用本文的文献
1
Way Forward: Gastrointestinal Tract Endoscopy Work Flow Postlockdown Era.前进方向：后封锁时代的胃肠道内镜检查工作流程
J Dig Endosc. 2020 Mar;11(1):89-91. doi: 10.1055/s-0040-1712335.
2
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.成人新冠病毒感染期间上呼吸道和肠道细菌微生物群评估：气消化道传播的可能性
Sci Rep. 2025 Jan 13;15(1):1811. doi: 10.1038/s41598-025-85806-5.
3
Surveillance strategies for SARS-CoV-2 infections through one health approach.通过“同一健康”方法对新冠病毒感染进行监测的策略。
Heliyon. 2024 Aug 30;10(17):e37128. doi: 10.1016/j.heliyon.2024.e37128. eCollection 2024 Sep 15.
4
Critical appraisal of how COVID-19 infection and imposed lockdowns have impacted gastroesophageal reflux: A review.新冠病毒感染和强制封锁对胃食管反流影响的批判性评价：综述。
Medicine (Baltimore). 2024 May 10;103(19):e38074. doi: 10.1097/MD.0000000000038074.
5
Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.间充质干细胞治疗 COVID-19 的临床试验。
Curr Stem Cell Res Ther. 2024;19(8):1055-1071. doi: 10.2174/011574888X260032230925052240.
6
Gastrointestinal symptoms among COVID-19 patients presenting to a primary health care center of Nepal: A cross-sectional study.尼泊尔一家初级卫生保健中心的新冠病毒疾病患者的胃肠道症状：一项横断面研究。
Health Sci Rep. 2023 Sep 14;6(9):e1568. doi: 10.1002/hsr2.1568. eCollection 2023 Sep.
7
Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication.了解血管紧张素转换酶2（ACE2）在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中的关键作用：从结构/功能到治疗意义。
Egypt J Med Hum Genet. 2022;23(1):103. doi: 10.1186/s43042-022-00314-9. Epub 2022 Jun 19.
8
Is SARS-CoV-2 a concern in the largest wastewater treatment plant in middle east?中东最大的污水处理厂中存在新冠病毒（SARS-CoV-2）问题吗？
Heliyon. 2023 Jun;9(6):e16607. doi: 10.1016/j.heliyon.2023.e16607. Epub 2023 May 24.
9
Digestive system infection by SARS‑CoV‑2: Entry mechanism, clinical symptoms and expression of major receptors (Review).消化系统感染 SARS-CoV-2：进入机制、临床症状和主要受体的表达（综述）。
Int J Mol Med. 2023 Mar;51(3). doi: 10.3892/ijmm.2023.5222. Epub 2023 Jan 20.
10
Evaluating the effects of air disinfectants in decontamination of COVID-19 aerosols.评估空气消毒剂对新冠病毒气溶胶的消毒效果。
Health Sci Rep. 2023 Jan 10;6(1):e1042. doi: 10.1002/hsr2.1042. eCollection 2023 Jan.
本文引用的文献
1
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
2
Prediction of Intrinsic Disorder in MERS-CoV/HCoV-EMC Supports a High Oral-Fecal Transmission.中东呼吸综合征冠状病毒/新型冠状病毒内在无序性的预测支持其高粪口传播性。
PLoS Curr. 2013 Nov 13;5:ecurrents.outbreaks.22254b58675cdebc256dbe3c5aa6498b. doi: 10.1371/currents.outbreaks.22254b58675cdebc256dbe3c5aa6498b.
3
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.冠状病毒相关严重急性呼吸综合征肺炎社区暴发中的临床进展与病毒载量：一项前瞻性研究。
Lancet. 2003 May 24;361(9371):1767-72. doi: 10.1016/s0140-6736(03)13412-5.
Zotero 插件